Lipogene Company, Inc. is a biotechnology company developing non-viral plasmid DNA therapeutics for diseases of the central nervous system. Lipogene is the non-viral solution to brain DNA drug delivery. Lipogenes proprietary pegylated immuno-liposome (PIL) technology enables delivery of non-viral plasmid DNA across the blood-brain barrier following non-invasive intravenous administration without viruses. Currently developing PILs for plasmid DNA drugs, with the PIL platform, Lipogene is addressing development of novel new plasma DNA therapeutic products for many brain diseases for which no existing therapy is now available.
